Phase I dose escalation study to evaluate the safety of T138067-sodium in patients with advanced refractory cancer
Phase of Trial: Phase I
Latest Information Update: 03 Feb 2010
At a glance
- Drugs Batabulin (Primary)
- Indications Cancer
- Focus Adverse reactions
- 17 Dec 2009 Actual end date (Jan 2001) added as reported by ClinicalTrials.gov.
- 17 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Oct 2005 New trial record.